![Hege Charlotte Bakken](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hege Charlotte Bakken
Directeur/Bestuurslid bij
AUSTEVOLL SEAFOOD ASA
Vermogen: 401 374 $ op 30-09-2026
Profiel
Hege Charlotte Bakken is currently the Deputy Chairman & Director at Austevoll Seafood ASA and a Director at Biomega Group AS.
She previously served as an Independent Director at Lerøy Seafood Group ASA, Director at Pronova BioPharma ASA, Director at Pronova Biopharma Norge AS, Director at Hofseth Biocare ASA, and Chief Operating Officer at Marvesa Rotterdam NV.
She also held the position of Chief Operating Officer at Marvesa Holding NV.
Bakken holds a graduate degree from the Norwegian University of Life Sciences and an MBA from ESCP Europe Campus London.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
Saga Pure ASA
 Saga Pure ASA Financial ConglomeratesFinance Provides investment services 0,37% | 30-06-2026 | 2.482.677 ( 0,37% ) | 401 374 $ | 30-09-2026 |
Actieve functies van Hege Charlotte Bakken
| Bedrijven | Functie | Begin |
|---|---|---|
| AUSTEVOLL SEAFOOD ASA | Directeur/Bestuurslid | 01-05-2018 |
Biomega Group AS
 Biomega Group AS BiotechnologyHealth Technology Operates as a biotechnology company specializing in bio-based processing and biorefining of Atlantic salmon residual raw materials | Directeur/Bestuurslid | 01-02-2023 |
Eerdere bekende functies van Hege Charlotte Bakken
| Bedrijven | Functie | Einde |
|---|---|---|
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets omega-3-derived pharmaceuticals | Directeur/Bestuurslid | - |
Pronova Biopharma Norge AS
 Pronova Biopharma Norge AS Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Directeur/Bestuurslid | - |
Marvesa Holding NV
 Marvesa Holding NV MiscellaneousMiscellaneous Functions as an investment holding and financing company | Operationeel Directeur | - |
| HOFSETH BIOCARE ASA | Directeur/Bestuurslid | - |
Marvesa Rotterdam NV | President | - |
Opleiding van Hege Charlotte Bakken
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Lerøy Seafood Group ASA
 Lerøy Seafood Group ASA Food: Meat/Fish/DairyConsumer Non-Durables Farms and processes fish | Consumer Non-Durables |
Pronova BioPharma ASA
Pronova BioPharma ASA Pharmaceuticals: OtherHealth Technology Develops, manufactures and markets omega-3-derived pharmaceuticals | Health Technology |
Austevoll Seafood ASA
 Austevoll Seafood ASA Food: Meat/Fish/DairyConsumer Non-Durables Engages in the farming, harvesting, processing, and distribution of seafood | Consumer Non-Durables |
Marvesa Rotterdam NV | |
Marvesa Holding NV
Marvesa Holding NV MiscellaneousMiscellaneous Functions as an investment holding and financing company | Miscellaneous |
Pronova Biopharma Norge AS
Pronova Biopharma Norge AS Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Norwegian University of Life Sciences
 Norwegian University of Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hofseth Biocare ASA
 Hofseth Biocare ASA Food: Specialty/CandyConsumer Non-Durables Engages in production of salmon oil, water-soluble protein and calcium | Consumer Non-Durables |
ESCP Europe Campus London
 ESCP Europe Campus London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biomega Group AS
Biomega Group AS BiotechnologyHealth Technology Operates as a biotechnology company specializing in bio-based processing and biorefining of Atlantic salmon residual raw materials | Health Technology |
